Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sphenopalatine Ganglion Block for Post-Dural Puncture Headache
NCT05253014Completed
- Start
- Jan 2018
- Primary completion
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of Lidocaine Hydrochloride Injection, without epinephrine and bupivacaine hydrochloride 0.75% injection in post-dural puncture headache (PDPH) (3 arms). Primary endpoint: Postdural Puncture Headache. Started Jan 2018; status: completed.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrinebupivacaine hydrochloride 0.75% injection
03
Conditions
post-dural puncture headache (PDPH)
Beyond the preview
Go deeper on NCT05253014.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05253014.